Shocking details of the tragedy

Matthew Perry is a favorite of millions of viewers of the series "Friends", who was found dead in his home on October 29 last year. This news was a real blow for his many fans and relatives. Recently, the police reported significant developments in the investigation of this case.

Crime and its consequences

The investigation, which has been going on since May, has finally brought results. It turned out that the death of the actor was caused by ketamine found in his blood. A week and a half before the tragedy, Perry underwent ketamine infusion therapy for depression and anxiety. However, it was this drug that became fatal for him, causing excessive stimulation of the cardiovascular system and respiratory depression.

"It's a hard road to the truth, but we won't stop until all those involved are exposed, " said a police representative.

Arrest and involved persons

The police announced the arrest of one person suspected of supplying ketamine. The investigation revealed a whole scheme in which several people may be involved. Several people are accused of the actor's death, and local media are waiting for the publicizing of the indictment by the prosecutors, which will detail all the circumstances of the case.

What's next?

It is known that the family of Matthew Perry is actively cooperating with law enforcement officers, seeking to establish justice. They hope the investigation will help prevent similar tragedies in the future.

"We have lost not only an actor, but also a friend, a man with a big soul and a brilliant talent. His death is a huge loss for all of us, " Perry's relatives say.

Summary and conclusions

The death of Matthew Perry overshadowed the lives of many of his fans and raised questions about the safety of the use of medical drugs. The investigation continues, and everyone is waiting for new details that will reveal the whole truth about this tragic event. The case promises to become a landmark in the fight against illegal drug trafficking, as well as improving control over the use of medical drugs.

Editor: Emiliia Morozova